community-acquired pneumonia

(redirected from Community acquired pneumonia)
Also found in: Acronyms.

community-acquired pneumonia (CAP),

pneumonia caused by any organism found regularly outside the hospital; common organisms include Streptococcus pneumoniae, Haemophilus influenzae, and Mycoplasma, as opposed to hospital-acquired or nosocomical pneumonia.

community-acquired pneumonia

(kə-myo͞o′nĭ-tē-)
n.
Pneumonia that a person acquires outside of a hospital or other health care institution, as distinguished from nosocomial, or hospital-acquired pneumonia.

community-acquired pneumonia

Pneumonia caused by an infection currently present in the community; CAP is the most common cause of infectious death–US, and number 6 killer overall; of the 57% of CAPs in which a pathogen is identified, S pneumoniae causes 60%, H influenzae 15%, Legionella pneumophila 10-15%, Staphylococcus aureus 2-10% Clinical Atypical pneumonia with delayed recognition; early SX are distinctly nonpulmonary–eg, dry cough, myalgia, arthralgia Diagnosis Pathogens in pleural fluid or blood cultures, Pneumocystis carinii in sputum or BAL, a 4-fold ↑ in Mycoplasma pneumoniae antibody titers, isolation of L pneumophila, or a 4-fold ↑ in L pneumophila antibody titers, or positive direct fluorescent antibody test for legionella, S pneumoniae antigen in serum, urine Risk factors Alcoholism, seizure disorders, smoking, immunosuppression

community-acquired pneumonia

Pneumonia occurring in outpatients, often caused by infection with streptococcus, Haemophilus influenzae, Staphylococcus aureus, and atypical organisms such as Legionella species. Mortality is approximately 15% but depends on many host and pathogen features.
See also: pneumonia
References in periodicals archive ?
However, non availablity of commercial assays such as immunofluorescence assay (IFA), microagglutination, indirect haemagglutination test and ELISA (4,12) in India has resulted in limited studies in community acquired pneumonia patients.
5-31 percent of sporadic community acquired pneumonia cases using variable detection assay as reported from different geographical location (10,15-23) (Table II).
A review of the Community Acquired Pneumonia products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
Coverage of the Community Acquired Pneumonia pipeline on the basis of route of administration and molecule type.
Companies discussed in this Community Acquired Pneumonia C Pipeline Review, H2 2014 report include AstraZeneca PLC, Biotest AG, C10 Pharma AS, Durata Therapeutics, Inc.
Drugs profile discussed in this Community Acquired Pneumonia C Pipeline Review, H2 2014 report include BT-086, C-10, dalbavancin, KRPAM-1977X, nemonoxacin, omadacycline, Small Molecules for SSTI and CAP Infections, ticagrelor.
New options are available for the treatment of acute bacterial exacerbations of chronic bronchitis and community acquired pneumonia.
The clinical areas are heart attack, coronary artery bypass graft, heart failure, community acquired pneumonia, and hip and knee replacement.
Premier ranked Kettering best in class for providing excellent care in total hip and knee replacement, open heart surgery, heart failure, pregnancy, community acquired pneumonia, and stroke for 2002 against the other subscribers to Perspective Online.
An application was submitted to the FDA requesting approval for FACTIVE for several indications, including community acquired pneumonia and acute exacerbation of chronic bronchitis.
It is approved to transmit data for all four ORYX hospital Core Measure sets: Heart Failure; Pregnancy and Related Conditions; Acute Myocardial Infarction; and Community Acquired Pneumonia.
MEDSTAT Core Measures(TM) is approved to transmit data for the following ORYX(R) measure sets: Heart Failure, Community Acquired Pneumonia (CAP), Acute Myocardial Infarction (AMI), and Pregnancy.

Full browser ?